4SC’s Next CEO Says Partner Talks Have Started on Cancer Drug

4SC AG’s newly announced Chief Executive Officer Enno Spillner said the company is in talks to find a partner for its experimental cancer drug resminostat and expects to start late-stage clinical trials by mid-2013.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.